1. Pan, Jinghua, Qiao, Yiting, Chen, Congcong, Chen, Jianxiang, Chen, Guo. 2021. USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1. In Cell death & disease, 12, 1051. doi:10.1038/s41419-021-04356-6. https://pubmed.ncbi.nlm.nih.gov/34741014/
2. Li, Juan, Wang, Yang, Luo, Yue, Yuan, Junying, Xiao, Zhi-Xiong Jim. 2022. USP5-Beclin 1 axis overrides p53-dependent senescence and drives Kras-induced tumorigenicity. In Nature communications, 13, 7799. doi:10.1038/s41467-022-35557-y. https://pubmed.ncbi.nlm.nih.gov/36528652/
3. Xia, Peng, Zhang, Hao, Lu, Haofeng, Zhang, Zhonglin, Yuan, Yufeng. 2023. METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression. In Cancer communications (London, England), 43, 338-364. doi:10.1002/cac2.12403. https://pubmed.ncbi.nlm.nih.gov/36602428/
4. Ning, Fengling, Du, Ling, Li, Jiayang, Yuan, Chunyan, Zhang, Xuemei. 2024. The deubiquitinase USP5 promotes cholangiocarcinoma progression by stabilizing YBX1. In Life sciences, 348, 122674. doi:10.1016/j.lfs.2024.122674. https://pubmed.ncbi.nlm.nih.gov/38692507/
5. Cao, Lei, Liu, Hongsheng, Huang, Cheng, Liang, Naixin, Li, Shanqing. 2023. USP5 knockdown alleviates lung cancer progression via activating PARP1-mediated mTOR signaling pathway. In Biology direct, 18, 16. doi:10.1186/s13062-023-00371-z. https://pubmed.ncbi.nlm.nih.gov/37060095/
6. Xiao, Wenjing, Wang, Jianqun, Wang, Xiaojing, Tong, Qiangsong, Zheng, Liduan. 2022. Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression. In Autophagy, 18, 2615-2635. doi:10.1080/15548627.2022.2044651. https://pubmed.ncbi.nlm.nih.gov/35253629/